|
G |
ACTA2 |
actin alpha 2, smooth muscle |
decreases expression multiple interactions |
EXP ISO |
mangostin results in decreased expression of ACTA2 protein [mangostin co-treated with MK 2206] results in decreased expression of ACTA2 protein; diphenyleneiodonium promotes the reaction [mangostin results in decreased expression of ACTA2 protein]; mangostin promotes the reaction [diphenyleneiodonium results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [mangostin results in decreased expression of ACTA2 protein] mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30502394 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
affects localization |
EXP |
mangostin affects the localization of AIFM1 protein |
CTD |
PMID:24480042 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
EXP |
mangostin results in decreased phosphorylation of AKT1 protein [mangostin co-treated with MK 2206] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:23954321 PMID:30502394 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
mangostin results in increased expression of BAX protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions |
EXP |
mangostin results in decreased expression of BCL2 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BID |
BH3 interacting domain death agonist |
decreases expression |
EXP |
mangostin results in decreased expression of BID protein |
CTD |
PMID:24480042 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein] |
CTD |
PMID:26357513 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
multiple interactions increases activity |
EXP |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] |
CTD |
PMID:24480042 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases activity |
EXP |
mangostin results in increased activity of CASP8 protein |
CTD |
PMID:24480042 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases activity |
EXP |
mangostin results in increased activity of CASP9 protein |
CTD |
PMID:23954321 PMID:24480042 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CYCS |
cytochrome c, somatic |
increases expression |
EXP |
mangostin results in increased expression of CYCS protein |
CTD |
PMID:24480042 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions decreases expression affects response to substance |
EXP |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] mangostin results in decreased expression of ESR1 protein ESR1 protein affects the susceptibility to mangostin |
CTD |
PMID:24480042 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein] |
CTD |
PMID:30502394 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
HDAC1 |
histone deacetylase 1 |
increases expression |
EXP |
mangostin results in increased expression of HDAC1 protein |
CTD |
PMID:30502394 |
|
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
|
|
G |
HMGB1 |
high mobility group box 1 |
multiple interactions decreases secretion |
ISO EXP |
mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of HMGB1 protein] mangostin results in decreased secretion of HMGB1 protein diphenyleneiodonium promotes the reaction [mangostin results in decreased secretion of HMGB1 protein]; mangostin affects the localization of and results in decreased acetylation of HMGB1 protein; mangostin promotes the reaction [diphenyleneiodonium results in decreased secretion of HMGB1 protein]; SIRT3 protein affects the reaction [mangostin results in decreased secretion of HMGB1 protein] |
CTD |
PMID:30502394 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAP2K1 protein |
CTD |
PMID:28722351 |
|
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
|
|
G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAP2K2 protein |
CTD |
PMID:28722351 |
|
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAP2K4 protein |
CTD |
PMID:28722351 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK1 protein mangostin analog results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK3 protein mangostin analog results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:28722351 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:28722351 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein] mangostin analog results in decreased expression of MMP2 mRNA; mangostin analog results in decreased expression of MMP2 protein |
CTD |
PMID:28722351 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein] mangostin analog results in decreased expression of MMP9 mRNA; mangostin analog results in decreased expression of MMP9 protein |
CTD |
PMID:28722351 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
mangostin results in increased cleavage of PARP1 protein |
CTD |
PMID:23954321 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
mangostin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] |
CTD |
PMID:18424012 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
SIRT3 |
sirtuin 3 |
increases expression multiple interactions |
EXP ISO |
mangostin results in increased expression of SIRT3 protein [mangostin co-treated with Carbon Tetrachloride] results in increased expression of and results in increased secretion of SIRT3 protein SIRT3 protein affects the reaction [mangostin results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [mangostin results in decreased secretion of HMGB1 protein] |
CTD |
PMID:30502394 |
|
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
|
|
G |
TFF1 |
trefoil factor 1 |
decreases expression |
EXP |
mangostin results in decreased expression of TFF1 protein |
CTD |
PMID:24480042 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
mangostin inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:18424012 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
increases expression multiple interactions |
EXP |
mangostin results in increased expression of TP53 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of TP53 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|